Skip to content
Screener

AOCI at other companies

West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
-$140.4M-58.3%
Trimas logo
TrimasTRS
-$210K+98.1%
Silgan Holdings logo
Silgan HoldingsSLGN
-$207.13M+12.0%
Amcor logo
AmcorAMCR
-$980M+10.3%
AMP
Amphastar PharmaceuticalsAMPH
-$5.9M-10.1%
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
-$7.83M+72.4%

Other financials

Income statement

See full
Revenue$982.9M+10.8%
Gross profit$351.9M+4.6%
Operating income$107.5M-5.2%
Net income$72.7M-7.8%
EPS (diluted)$1.12-4.3%

Balance sheet

See full
Cash & equivalents$225.0M+78.8%
Total debt$1.4B+32.7%
Total equity$2.6B+3.6%
Total assets$5.1B+12.6%

Cash flow

See full
Operating cash flow$118.7M+43.5%
CapEx$65.4M+15.0%
Free cash flow$53.3M+106%

Valuation

See full
Market cap$8.69B-4.7%
Enterprise value$9.9B-2.2%
P/E22.5×-0.8×
P/S2.3×-0.3×

Profitability

See full
Gross margin36.7%-1.6pp
Operating margin12.8%-1.2pp
Net margin10%-0.4pp
FCF margin8.4%-2.1pp

Returns & leverage

See full
Return on equity15%-0.2pp
Debt / equity0.5×+0.1×
Current ratio1.7×+0.4×

Where this comes from

Reported directly by AptarGroup in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The source filing: AptarGroup’s 10-Q, filed May 1, 2026.

Filed
May 1, 2026, 11:22 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000896622-26-000092
In thousands, except share and per share amountsMarch 31, 2026December 31, 2025
Common stock, $.01 par value, 199.0 million shares authorized, 73.1 million and 72.8 million shares issued as of March 31, 2026 and December 31, 2025, respectively731728
Capital in excess of par value1,192,7051,165,518
Retained earnings2,684,3822,642,552
Accumulated other comprehensive loss(198,716)(186,382)
Less: Treasury stock at cost, 9.2 million and 8.6 million shares as of March 31, 2026 and December 31, 2025(1,049,607)(954,320)
Total AptarGroup, Inc. Stockholders’ Equity2,629,4952,668,096
Noncontrolling interests in subsidiaries18,06217,885
Total Stockholders’ Equity2,647,5572,685,981

ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)

FAQ

What is AptarGroup's AOCI?
AptarGroup (ATR) reported AOCI of -$198.72M in Q1 2026.
How has AptarGroup's AOCI changed year-over-year?
AptarGroup's AOCI increased by 43.4% year-over-year, from -$350.86M to -$198.72M.
What is the long-term trend for AptarGroup's AOCI?
Over 5 years (2020 to 2025), AptarGroup's AOCI has grown at a -7.9% compound annual growth rate (CAGR), from -$281.71M to -$186.38M.
What does AOCI mean?
Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.

Ask your AI about AptarGroup's aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude